This article from Bio-IT World reminds that it is important for CRO’s to use high-performance laboratory information management systems (LIMS). Sponsor companies and CRO’s who use LIMS, will see a lower “barrier entry” when dealing with regulatory agencies in respective countries. LIMS are helpful in gathering, analyzing and storing data for the CRO’s sponsors. It is especially important to be aware of regulations since on average bringing a new drug to market takes 15 years, and costs $2 billion.
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
September
(20)
- Clinical Trials in an Emerging Brazilian Market
- inVentiv Clinical Solutions expands into Europe
- Kendle International
- Some clinical trial results not published
- Quintiles will become largest Asia-Pacific clinica...
- Guidelines to choosing your CRO
- Indian Share of the Clinical Trial Market
- No Need to Fear the EU Clinical Trial Directive
- Drug Approvals
- Role of LIMS
- NiKem is Accepted by the FMR
- Phase I Trial Outsourcing in India by 2010?
- Indian government looking into regulation of Clini...
- Drug Industry's Rush to Outsource
- Gryphon Investors Invests in CROs
- Clinical trial for autoimmune drug halts
- Technology and Clinical Trials
- Tips to get to Clinic Faster
- Acurian expands patient model
- Update: Indian Institute and the death of babies ...
-
▼
September
(20)
No comments:
Post a Comment